Nuveen Asset Management, LLC Vista Gen Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.09 - $0.16 $3,065 - $5,450	-34,065 Reduced 5.76%	557,613 $597,000
Q3 2022 Nov 14, 2022	SELL	$0.14 - $1.07 $277 - $2,120	-1,982 Reduced 0.33%	591,678 $633,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.73 $13,760 - $27,052	-15,637 Reduced 2.57%	593,660 $523,000
Q1 2022 May 16, 2022	BUY	$1.14 - $2.09 $9,400 - $17,234	8,246 Added 1.37%	609,297 $719,000
Q4 2021 Feb 14, 2022	SELL	$1.67 - $2.76 $97,372 - $160,927	-58,307 Reduced 8.84%	601,051 $1.05 Million

Q3 2021 Nov 12, 2021	SELL	$2.62 - $3.45 $70,797 - $93,225	-27,022 Reduced 3.94%	659,358 $1.97 Million
Q2 2021 Aug 16, 2021	BUY	$1.96 - $3.15 $1.35 Million - $2.16 Million	686,380 New	686,380 $2.16 Million

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $720M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.